Christopher G. Rowan

897 total citations
33 papers, 643 citations indexed

About

Christopher G. Rowan is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Biomedical Engineering. According to data from OpenAlex, Christopher G. Rowan has authored 33 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 7 papers in Cardiology and Cardiovascular Medicine and 7 papers in Biomedical Engineering. Recurrent topics in Christopher G. Rowan's work include Potassium and Related Disorders (13 papers), Membrane-based Ion Separation Techniques (6 papers) and Heart Failure Treatment and Management (5 papers). Christopher G. Rowan is often cited by papers focused on Potassium and Related Disorders (13 papers), Membrane-based Ion Separation Techniques (6 papers) and Heart Failure Treatment and Management (5 papers). Christopher G. Rowan collaborates with scholars based in United States, Iran and Finland. Christopher G. Rowan's co-authors include David L. Lacey, James Flory, Deborah Wilkerson, Michael Krychman, JL Nichol, Esther Choi, Edward M. Dwyer, Steve Kaufman, MM Hokom and Timothy G. Grasel and has published in prestigious journals such as Circulation, Blood and PLoS ONE.

In The Last Decade

Christopher G. Rowan

32 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher G. Rowan United States	15	133	126	124	94	90	33	643
B. Agroyannis Greece	15	101 0.8×	166 1.3×	143 1.2×	80 0.9×	25 0.3×	50	694
Goce Spasovski North Macedonia	16	46 0.3×	212 1.7×	174 1.4×	56 0.6×	47 0.5×	108	1.1k
Raj Thuraisingham United Kingdom	20	120 0.9×	118 0.9×	298 2.4×	272 2.9×	25 0.3×	50	1.1k
Anne B. Taegtmeyer Switzerland	16	40 0.3×	130 1.0×	105 0.8×	131 1.4×	28 0.3×	50	709
Shinobu Tatsunami Japan	14	41 0.3×	112 0.9×	220 1.8×	23 0.2×	91 1.0×	36	1.1k
Anna Margrethe Thøgersen Denmark	17	141 1.1×	165 1.3×	207 1.7×	790 8.4×	47 0.5×	52	1.3k
G. Freyburger France	16	187 1.4×	148 1.2×	211 1.7×	174 1.9×	53 0.6×	34	881
Adis Tasanarong Thailand	14	33 0.2×	144 1.1×	186 1.5×	60 0.6×	13 0.1×	36	982
Yusuke Watanabe Japan	17	21 0.2×	147 1.2×	115 0.9×	134 1.4×	33 0.4×	56	1.0k
Jung Hun Ohn South Korea	15	206 1.5×	46 0.4×	143 1.2×	85 0.9×	24 0.3×	57	963

Countries citing papers authored by Christopher G. Rowan

Since Specialization

Citations

This map shows the geographic impact of Christopher G. Rowan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher G. Rowan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher G. Rowan more than expected).

Fields of papers citing papers by Christopher G. Rowan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher G. Rowan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher G. Rowan. The network helps show where Christopher G. Rowan may publish in the future.

Co-authorship network of co-authors of Christopher G. Rowan

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher G. Rowan. A scholar is included among the top collaborators of Christopher G. Rowan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher G. Rowan. Christopher G. Rowan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rowan, Christopher G., Munawwar Sajjad, Rutao Yao, et al.. (2025). Cocaine self-administration attenuates brain glucose metabolism and functional connectivity in rats. PLoS ONE. 20(6). e0324522–e0324522. 1 indexed citations

Rowan, Christopher G., Russell Nichols, Neil Dhopeshwarkar, et al.. (2024). Real-World Effectiveness of Bebtelovimab Versus Nirmatrelvir/Ritonavir in Outpatients with COVID-19. Pulmonary Therapy. 11(1). 55–67.

Rowan, Christopher G., Abiy Agiro, K. Arnold Chan, et al.. (2024). Hyperkalemia Recurrence Following Medical Nutrition Therapy in Patients with Stage 3–4 Chronic Kidney Disease: The REVOLUTIONIZE I Real-World Study. Advances in Therapy. 41(6). 2381–2398. 2 indexed citations

Agiro, Abiy, Christopher G. Rowan, Pooja Desai, et al.. (2023). Abstract 11709: High Rates of Hyperkalemia Recurrence After Medical Nutrition Therapy in Patients With Heart Failure: REVOLUTIONIZE I Real-World Evidence Study. Circulation. 148(Suppl_1). 1 indexed citations

Desai, Nihar R., et al.. (2021). Healthcare utilization and expenditures associated with hyperkalemia management: a retrospective study of Medicare Advantage patients. Journal of Medical Economics. 24(1). 1025–1036. 4 indexed citations

Coca, Steven G., et al.. (2021). Comparative Effectiveness of Patiromer and RAAS Inhibitor Continuation vs. No Potassium Binder and Discontinued RAAS Inhibitors on Healthcare Resource Utilization and Cost Outcomes in Hyperkalemia. Journal of the American Society of Nephrology. 32(10S). 7–8. 1 indexed citations

Desai, Nihar R., et al.. (2020). Hyperkalemia treatment modalities: A descriptive observational study focused on medication and healthcare resource utilization. PLoS ONE. 15(1). e0226844–e0226844. 14 indexed citations

Kövesdy, Csaba P., et al.. (2020). Real-world management of hyperkalemia with patiromer among United States Veterans. Postgraduate Medicine. 132(2). 176–183. 21 indexed citations

Desai, Nihar R., et al.. (2019). Patiromer and maintenance of RAASi therapy in hyperkalemic medicare patients. PubMed Central. 8(sup1). 2–2. 1 indexed citations

10.

Kövesdy, Csaba P., Christopher G. Rowan, Ansgar Conrad, et al.. (2018). Real-World Evaluation of Patiromer for the Treatment of Hyperkalemia in Hemodialysis Patients. Kidney International Reports. 4(2). 301–309. 36 indexed citations

11.

Krychman, Michael, et al.. (2017). Effect of Single-Session, Cryogen-Cooled Monopolar Radiofrequency Therapy on Sexual Function in Women with Vaginal Laxity: The VIVEVE I Trial. Journal of Women s Health. 27(3). 297–304. 34 indexed citations

12.

Flory, James, et al.. (2017). Comparative adherence to diabetes drugs: A n analysis of electronic health records and claims data. Diabetes Obesity and Metabolism. 19(8). 1184–1187. 12 indexed citations

13.

Rowan, Christopher G., et al.. (2014). Antihypertensive treatment and blood pressure control relative to hypertension treatment guidelines. Pharmacoepidemiology and Drug Safety. 23(12). 1294–1302. 15 indexed citations

14.

Flory, James, Bonnie Ky, Kevin Haynes, et al.. (2012). Observational cohort study of the safety of digoxin use in women with heart failure. BMJ Open. 2(2). e000888–e000888. 17 indexed citations

15.

Rowan, Christopher G., Allen Brinker, Parivash Nourjah, et al.. (2009). Rhabdomyolysis reports show interaction between simvastatin and CYP3A4 inhibitors. Pharmacoepidemiology and Drug Safety. 18(4). 301–309. 41 indexed citations

16.

Lynch, Katherine E., Harold I. Feldman, Jesse A. Berlin, et al.. (2008). Effects of l-Carnitine on Dialysis-Related Hypotension and Muscle Cramps: A Meta-analysis. American Journal of Kidney Diseases. 52(5). 962–971. 40 indexed citations

17.

Senaldi, Giorgio, et al.. (1998). Keratinocyte growth factor protects murine hepatocytes from tumor necrosis factor-induced apoptosis in vivo and in vitro. Hepatology. 27(6). 1584–1591. 46 indexed citations

18.

Agnello, Davide, Cristina Meazza, Christopher G. Rowan, et al.. (1998). Leptin causes body weight loss in the absence of in vivo activities typical of cytokines of the IL-6 family. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 275(3). R913–R919. 15 indexed citations

19.

Rowan, Christopher G.. (1995). Excimer lasers drill precise holes with higher yields. 31(8). 81–83. 8 indexed citations

20.

Hokom, MM, David L. Lacey, Esther Choi, et al.. (1995). Pegylated megakaryocyte growth and development factor abrogates the lethal thrombocytopenia associated with carboplatin and irradiation in mice. Blood. 86(12). 4486–4492. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact